Your browser doesn't support javascript.
loading
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?
Teixeira, Natalia; van der Hout, Annemieke; Oosterwijk, Jan C; Vos, Janet R; Devilee, Peter; van Engelen, Klaartje; Meijers-Heijboer, Hanne; van der Luijt, Rob B; Kriege, Mieke; Mensenkamp, Arjen R; Rookus, Matti A; van Roozendaal, Kees E; Mourits, Marian J E; de Bock, Geertruida H.
Afiliação
  • Teixeira N; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. n.teixeira@umcg.nl.
  • van der Hout A; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Oosterwijk JC; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Vos JR; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Engelen K; Department of Human Genetics, Leiden University Medical Center, University of Leiden, Leiden, The Netherlands.
  • Meijers-Heijboer H; Department of Clinical Genetics, VU University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • van der Luijt RB; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Kriege M; Department of Clinical Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
  • Mensenkamp AR; Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Rookus MA; Department of Human Genetics, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands.
  • van Roozendaal KE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mourits MJE; Department of Clinical Genetics, University Hospital of Maastricht, University of Maastricht, Maastricht, The Netherlands.
  • de Bock GH; Department of Gynecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Eur J Hum Genet ; 26(6): 848-857, 2018 06.
Article em En | MEDLINE | ID: mdl-29483665
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article